Endovascular Versus Open Repair of the Common Femoral Artery

Endovascular Versus Open Repair of the Common Femoral Artery: a Randomized Trial (TECCO)

Even though the indication for endovascular therapy has been enlarged, open repair of common femoral artery is still considered as the treatment of choice. A recent pilot study showed that endovascular repair of the CFA seems to be a safe technique of revascularization with acceptable initial results at 12 months (Azema et al, Eur J Vasc Endovasc Surg, 2011, in press). TECCO, a French randomized and controlled trial, has been set up to compare open and endovascular procedures for the treatment of CFA atherosclerotic lesions.

Inclusion Criteria:

• Age between 40 and 90 years-old
• De novo atheromatous common femoral artery stenosis
• Symptomatic lesions (Rutherford stages 3, 4, 5 and 6)
• Haemodynamically significant lesion
• Written informed consent

Exclusion Criteria:

• Restenosis
• Non-atheromatous lesions (dysplasia, post-traumatic, inflammatory)
• external iliac thrombosis and / or common femoral side to treat
• Contraindication to open surgery or endovascular treatment
• Contraindication to anesthesia
• Indication of aorto-femoral, ilio-femoral, femoral-popliteal or femoro-tibialis bypass to associate with the common femoral revascularization
• Indication of a surgical approach to the external iliac artery through a retroperitoneal
• Asymptomatic lesions
• Life expectancy less than one year
• Refusing patient
• Inability to monitor during the test period
• Participation in another clinical trial
• Pregnant Women
• No written informed consent